These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
379 related articles for article (PubMed ID: 32881895)
1. COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology. White NJ; Watson JA; Hoglund RM; Chan XHS; Cheah PY; Tarning J PLoS Med; 2020 Sep; 17(9):e1003252. PubMed ID: 32881895 [TBL] [Abstract][Full Text] [Related]
2. Safety considerations for chloroquine and hydroxychloroquine in the treatment of COVID-19. Gevers S; Kwa MSG; Wijnans E; van Nieuwkoop C Clin Microbiol Infect; 2020 Sep; 26(9):1276-1277. PubMed ID: 32422406 [No Abstract] [Full Text] [Related]
3. Insights from nanomedicine into chloroquine efficacy against COVID-19. Hu TY; Frieman M; Wolfram J Nat Nanotechnol; 2020 Apr; 15(4):247-249. PubMed ID: 32203437 [TBL] [Abstract][Full Text] [Related]
4. Chloroquine and hydroxychloroquine in coronavirus disease 2019 (COVID-19). Facts, fiction and the hype: a critical appraisal. Khuroo MS Int J Antimicrob Agents; 2020 Sep; 56(3):106101. PubMed ID: 32687949 [TBL] [Abstract][Full Text] [Related]
5. In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Yao X; Ye F; Zhang M; Cui C; Huang B; Niu P; Liu X; Zhao L; Dong E; Song C; Zhan S; Lu R; Li H; Tan W; Liu D Clin Infect Dis; 2020 Jul; 71(15):732-739. PubMed ID: 32150618 [TBL] [Abstract][Full Text] [Related]
6. Update on use of chloroquine/hydroxychloroquine to treat coronavirus disease 2019 (COVID-19). Gao J; Hu S Biosci Trends; 2020 May; 14(2):156-158. PubMed ID: 32281583 [TBL] [Abstract][Full Text] [Related]
7. Do we have enough evidence to use chloroquine/hydroxychloroquine as a public health panacea for COVID-19? Palmeira VA; Costa LB; Perez LG; Ribeiro VT; Lanza K; Silva ACSE Clinics (Sao Paulo); 2020; 75():e1928. PubMed ID: 32401962 [No Abstract] [Full Text] [Related]
8. Pharmacokinetic Basis of the Hydroxychloroquine Response in COVID-19: Implications for Therapy and Prevention. Tarek M; Savarino A Eur J Drug Metab Pharmacokinet; 2020 Dec; 45(6):715-723. PubMed ID: 32780273 [TBL] [Abstract][Full Text] [Related]
9. ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial. McEniery CM; Fisk M; Miles K; Kaloyirou F; Hubsch A; Smith J; Wilkinson IB; Cheriyan J Trials; 2020 Jul; 21(1):604. PubMed ID: 32616067 [TBL] [Abstract][Full Text] [Related]
10. Chloroquine as a prophylactic agent against COVID-19? Gendrot M; Javelle E; Clerc A; Savini H; Pradines B Int J Antimicrob Agents; 2020 Jun; 55(6):105980. PubMed ID: 32294495 [TBL] [Abstract][Full Text] [Related]
11. COVID-19 and Chloroquine/Hydroxychloroquine: Is There Ophthalmological Concern? Marmor MF Am J Ophthalmol; 2020 Aug; 216():A1-A2. PubMed ID: 32439074 [No Abstract] [Full Text] [Related]
12. Hydroxychloroquine efficacy and safety in preventing SARS-CoV-2 infection and COVID-19 disease severity during pregnancy (COVID-Preg): a structured summary of a study protocol for a randomised placebo controlled trial. González R; García-Otero L; Pons-Duran C; Marbán-Castro E; Goncé A; Llurba E; Gil MDM; Rodríguez-Zambrano MÁ; Chen H; Ramírez M; Bardají A; Menendez C Trials; 2020 Jul; 21(1):607. PubMed ID: 32616063 [TBL] [Abstract][Full Text] [Related]
13. Chloroquine and Hydroxychloroquine in COVID-19: Challenges and the Need for Caution in Low-Resource Settings. Islam M J Coll Physicians Surg Pak; 2020 Jun; 30(6):78. PubMed ID: 32723461 [No Abstract] [Full Text] [Related]
14. Hydroxychloroquine or Chloroquine for Treatment or Prophylaxis of COVID-19: A Living Systematic Review. Hernandez AV; Roman YM; Pasupuleti V; Barboza JJ; White CM Ann Intern Med; 2020 Aug; 173(4):287-296. PubMed ID: 32459529 [TBL] [Abstract][Full Text] [Related]
15. Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection. Juurlink DN CMAJ; 2020 Apr; 192(17):E450-E453. PubMed ID: 32269021 [No Abstract] [Full Text] [Related]
16. Chloroquine or hydroxychloroquine for prophylaxis of COVID-19. Principi N; Esposito S Lancet Infect Dis; 2020 Oct; 20(10):1118. PubMed ID: 32311322 [No Abstract] [Full Text] [Related]
17. Novel approach for low-dose pulmonary delivery of hydroxychloroquine in COVID-19. Fassihi SC; Nabar NR; Fassihi R Br J Pharmacol; 2020 Nov; 177(21):4997-4998. PubMed ID: 32562278 [No Abstract] [Full Text] [Related]
18. Chloroquine and hydroxychloroquine in the treatment of malaria and repurposing in treating COVID-19. Lei ZN; Wu ZX; Dong S; Yang DH; Zhang L; Ke Z; Zou C; Chen ZS Pharmacol Ther; 2020 Dec; 216():107672. PubMed ID: 32910933 [TBL] [Abstract][Full Text] [Related]
19. Chloroquine and hydroxychloroquine for the prevention and therapy of coronavirus disease 2019: new hopes and old cardiovascular concerns. Jankowska EA; Sierpiński R; Tkaczyszyn M; Drozd M; Szachniewicz J; Duda-Sikuła M; Knysz B; Simon K; Szenborn L; Ponikowski P Kardiol Pol; 2020 Aug; 78(7-8):811-817. PubMed ID: 32687267 [No Abstract] [Full Text] [Related]
20. Therapeutic use of chloroquine and hydroxychloroquine in COVID-19 and other viral infections: A narrative review. Hashem AM; Alghamdi BS; Algaissi AA; Alshehri FS; Bukhari A; Alfaleh MA; Memish ZA Travel Med Infect Dis; 2020; 35():101735. PubMed ID: 32387694 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]